Artivion (AORT) SVP, General Counsel reports stock award and tax-cover sales

Rhea-AI Filing Summary

ARTIVION, INC. executive Jean F. Holloway, SVP and General Counsel, reported equity compensation activity and related tax sales in company stock. She acquired 27,795 shares of common stock on a grant or award basis at $0.00 per share, tied to performance stock units granted in February 2025, with remaining portions scheduled to vest in February 2027 and February 2028 subject to continued employment. Following this vesting, she sold 3,843 shares at an average price of $37.7756 on March 3, 2026 and 8,962 shares at $38.00 on March 4, 2026 solely to cover tax withholding obligations under a “sell to cover” arrangement, which the filing states is not a discretionary transaction. After these transactions, she directly owned 185,095 shares of Artivion common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Holloway Jean F

(Last) (First) (Middle)

1655 ROBERTS BLVD., NW

(Street)

KENNESAW GA 30144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		A		27,795(1)	A	$0	197,900	D
Common Stock	03/03/2026		S		3,843(2)	D	$37.7756	194,057	D
Common Stock	03/04/2026		S		8,962	D	$38(3)	185,095	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date.

2. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

3. Reflects the price the shares were sold.

Remarks:

	/s/ Jean F Holloway	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did AORT executive Jean Holloway report?

Jean Holloway reported a stock award vesting and related tax sales. She acquired 27,795 Artivion common shares from performance stock units, then sold 12,805 shares in two transactions to cover tax withholding, leaving 185,095 shares directly owned afterward.

Were Jean Holloway’s AORT stock sales discretionary trades?

The reported Artivion stock sales were not discretionary. The filing states the 3,843 and 8,962 shares were sold solely to satisfy tax withholding obligations under a “sell to cover” arrangement following vesting of performance stock units.

How many AORT shares did Jean Holloway sell and at what prices?

Jean Holloway sold 3,843 Artivion common shares at an average price of $37.7756 and 8,962 shares at $38.00. Both transactions followed performance stock unit vesting and were executed to cover related tax withholding obligations.

What performance stock unit vesting schedule applies to Jean Holloway’s AORT grant?

Her performance stock units were granted in February 2025. One third vested and was issued on March 2, 2026, with additional one-third portions eligible to vest on February 28, 2027 and February 28, 2028, contingent on continued employment at each vesting date.

How many AORT shares does Jean Holloway own after these transactions?

After the reported grant vesting and tax-related sales, Jean Holloway directly owns 185,095 shares of Artivion common stock. This figure reflects her holdings following the final March 4, 2026 sale of 8,962 shares to cover tax withholding.

What role does Jean Holloway hold at Artivion (AORT)?

Jean F. Holloway serves as Senior Vice President and General Counsel at Artivion. Her Form 4 filing reflects equity compensation and tax-related share sales associated with this executive role, including performance stock unit vesting and related “sell to cover” transactions.